KRISTINA KRUSE: Open Payments
NPI 1891288007 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 11 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $64 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ABBVIE INC. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: PREVNAR 20, Kerendia, VRAYLAR, AIRSUPRA, Ozempic, MOUNJARO, FARXIGA, UBRELVY.
Industry payments across GA — which companies pay providers there.
